NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE
OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A
VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION
FOR IMMEDIATE RELEASE
5 June 2026
Bodycote plc
Response to statement by Apollo
The Board of Bodycote plc ("Bodycote") notes the statement by Apollo Management
X, L.P. (together with Apollo Global Management, Inc. and its subsidiaries
("Apollo")), on behalf of certain of its managed investment funds, that it does
not intend to make a firm offer for Bodycote and that it is consequently bound
by the restrictions under Rule 2.8 of the City Code on Takeovers and Mergers
(the "Code").
The Board of Bodycote has strong confidence in Bodycote's potential and its
strategy to create a high-performing, resilient business with attractive growth
prospects. Bodycote continues to execute well on the group's Optimise, Perform
and Grow initiatives, with a positive start to 2026 trading as set out in the
AGM trading update of 27 May 2026.
As a result of the announcement by Apollo, Bodycote is no longer in an offer
period for the purposes of the Code.
Enquiries:
Bodycote plc +44 (0) 16 2550 5300
Jim Fairbairn, Chief Executive Officer
Ben Fidler, Chief Financial Officer
Peter Lapthorn, Head of FP&A and Investor Relations
FTI Consulting +44 (0) 20 3727 1340
(PR Adviser)
Richard Mountain
Edward Knight
Barclays Bank PLC, Goldman Sachs International and Jefferies are acting as
financial advisers to Bodycote.
Disclaimers
Barclays Bank PLC, acting through its Investment Bank ("Barclays"), which is
authorised by the Prudential Regulation Authority and regulated in the United
Kingdom by the Financial Conduct Authority and the Prudential Regulation
Authority, is acting exclusively for Bodycote and no one else in connection with
the matters set out in this announcement and will not be responsible to anyone
other than Bodycote for providing the protections afforded to clients of
Barclays nor for providing advice in relation to any matter referred to in this
announcement.
In accordance with the Code, normal United Kingdom market practice and Rule 14e
-5(b) of the Securities Exchange Act 1934 of the United States, Barclays and its
affiliates will continue to act as exempt principal trader in Bodycote
securities on the London Stock Exchange. These purchases and activities by
exempt principal traders which are required to be made public in the United
Kingdom pursuant to the Code will be reported to a Regulatory Information
Service and will be available on the London Stock Exchange website at
www.londonstockexchange.com. This information will also be publicly disclosed in
the United States to the extent that such information is made public in the
United Kingdom.
Goldman Sachs International, which is authorised by the Prudential Regulation
Authority and regulated by the Financial Conduct Authority and the Prudential
Regulation Authority in the United Kingdom, is acting exclusively for Bodycote
and no one else in connection with the matters referred to in this announcement
and will not be responsible to anyone other than Bodycote for providing the
protections afforded to clients of Goldman Sachs International, or for providing
advice in connection with the matters referred to in this announcement.
Jefferies International Limited ("Jefferies"), which is authorised and regulated
by the FCA in the UK, is acting exclusively as financial adviser and corporate
broker to Bodycote and no one else in connection with the matters described in
this announcement and will not regard any other person as its client in relation
to the matters in this announcement and will not be responsible to anyone other
than Bodycote for providing the protections afforded to clients of Jefferies nor
for providing advice in relation to any matter referred to in this announcement.
Neither Jefferies nor any of its affiliates (nor their respective directors,
officers, employees or agents) owes or accepts any duty, liability or
responsibility whatsoever (whether direct or indirect, whether in contract, in
tort, under statute or otherwise) to any person who is not a client of Jefferies
in connection with this announcement, any statement contained herein or
otherwise.
Additional Information
This announcement is not intended to, and does not, constitute or form part of
any offer, invitation or the solicitation of an offer to purchase, otherwise
acquire, subscribe for, sell or otherwise dispose of, any securities, or the
solicitation of any vote or approval in any jurisdiction, pursuant to this
announcement or otherwise.
This announcement has been prepared in accordance with English law and
information disclosed may not be the same as that which would have been
disclosed in accordance with the laws of jurisdictions outside England. The
release, publication or distribution of this announcement in whole or in part,
directly or indirectly, in, into or from certain jurisdictions other than the
United Kingdom and the availability of any offer to shareholders of Bodycote
should one be made who are not resident in the United Kingdom may be affected by
the laws of relevant jurisdictions. Therefore, any persons who are subject to
the laws of any jurisdiction other than the United Kingdom or shareholders of
Bodycote who are not resident in the United Kingdom will need to inform
themselves about, and observe, any applicable requirements.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/bodycote-plc/r/response-to-statement-by-apollo,c4358292